Potential of bone scaffolds containing vancomycin and bone morphogenetic protein-2 in a rat model of osteomyelitis

1. Seligson D, Klemm K. Adult posttraumatic osteomyelitis of the tibial diaphysis of the tibial shaft. Clin Orthop. 1999; 360:30-6.10.1097/00003086-199903000-00006Search in Google Scholar

2. Price JS, Tencer AF, Arm DM, Bohach GA. Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res. 1996; 30:281-6.10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-MOpen DOISearch in Google Scholar

3. Gustilo RB, Merkow RL, Templeman D. The management of open fractures. J Bone Joint Surg. 1990; 72:299-304.10.2106/00004623-199072020-00023Open DOISearch in Google Scholar

4. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007; 298:1763-71.10.1001/jama.298.15.1763Search in Google Scholar

5. Farooq AH, Dabke HV, Majeed MA, Carbarns NJ, Mackie IG. Clostridial wound infection following reconstruction of the anterior cruciate ligament using bone-patella-bone autograft. J Coll Physicians Surg Pak. 2007; 17:369-70.Search in Google Scholar

6. Bruce JN, Bruce SS. Preservation of bone flaps in patients with postcraniotomy infections. J Neurosurg. 2003; 98:1203-7.10.3171/jns.2003.98.6.1203Open DOISearch in Google Scholar

7. Shorr AF. Epidemiology of staphylococcal resistance. Clin Infect Dis. 2007; 45:S171-6.10.1086/519473Open DOISearch in Google Scholar

8. Reddi AH. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng. 2000; 6:351-9.10.1089/107632700418074Open DOISearch in Google Scholar

9. Thanyaphoo S, Kaewsrichan J. Synthesis and evaluation of novel glass ceramics as drug delivery systems in osteomyelitis. J Pharm. Sci. 2012; 101: 2870-82.10.1002/jps.23230Open DOISearch in Google Scholar

10. Diniza SOF, Rezendeb CMF, Serakidesb R, Ferreiraa RLB, Ribeiroa TG, Martin-Cominc J, et al. Scintigraphic imaging using technetium-99m-labeled ceftizoxime in an experimental model of acute osteomyelitis in rats. Nuclear Med Commu. 2008; 29:830-6.10.1097/MNM.0b013e3283000514Open DOISearch in Google Scholar

11. Li B, Brown KV, Wenke JC, Guelcher SA. Sustained release of vancomycin from polyurethane scaffolds inhibits infection of bone wounds in a rat femoral segmental defect model. J Control Release. 2010; 145: 221-30.10.1016/j.jconrel.2010.04.002Search in Google Scholar

12. Brown KV, Walker JA, Cortez DS, Murray CK, Wenke JC. Earlier debridement and antibiotic administration decreases infection. J Surg Orthop Adv. 2010; 19: 18-22.Search in Google Scholar

13. Zhang X, Wyss UP, Pichora D, Goosen MF. Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties. J Pharm Pharmacol. 1994; 46:718-24.10.1111/j.2042-7158.1994.tb03890.x7837040Open DOISearch in Google Scholar

14. Nijhof MW, Fleer A, Hardus K, Vogely HC, Schouls LM, Verbout AJ, et al. Tobramycin containing bone cement and systemic cefazolin in a one-stage revision. Treatment of infection in a rabbit model. J Biomed Mater Res. 2001; 58:747-53.10.1002/jbm.107311745530Open DOISearch in Google Scholar

15. Mayberry-Carson KJ, Tober-Meyer B, Lambe DW, Jr. Costerton JW. Osteomyelitis experimentally induced with Bacteroides thetaiotaomicron and Staphylococcus epidermidis. Influence of a foreign-body implant. Clin Orthopaedics. 1992; 280:289-99.10.1097/00003086-199207000-00040Search in Google Scholar

16. Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of metaanalysis. Nucl Med Commun. 2006; 27:757-64.10.1097/01.mnm.0000230065.85705.b316969256Open DOISearch in Google Scholar

17. Enderle MD, Coerper S, Schweizer HP, Kopp AE, Thelen MH, Meisner C, et al. Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of high resolution ultrasound. Diabetes Care. 1999; 22:294-9.10.2337/diacare.22.2.29410333948Open DOISearch in Google Scholar

18. Hauser CJ, Adams CA, Jr. Eachempati SR. Surgical Infection Society guideline: prophylactic antibiotic use in open fractures: an evidence-based guideline. Surg Infect (Larchmt). 2006; 7:379-405.10.1089/sur.2006.7.37916978082Search in Google Scholar

19. Ahn SH, Kim CS, Suk HJ, Lee YJ, Choi SH, Chai JK, et al. Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects. J Periodontol. 2003; 74:787-97.10.1902/jop.2003.74.6.78712886988Search in Google Scholar

20. Hollinger JO, Schmitt JM, Buck DC, Shannon R, Joh SP, Zegzula HD, et al. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration, J Biomed Mater Res. 1998; 43:356-64.Search in Google Scholar

21. Hong L, Tabata Y, Yamamoto M, Miyamoto S, Yamada K, Hashimoto N, et al. Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution, J Biomater Sci Polym Ed. 1998; 9: 1001-14. Search in Google Scholar